Novavax (NVAX) Tax Provisions (2010 - 2026)

Novavax's Tax Provisions history runs 9 years deep, the most recent figure standing at $985000.0 for Q1 2026.

• In Q1 2026, Tax Provisions fell 17.92% year-over-year to $985000.0; the TTM figure through Mar 2026 stood at $1.6 million (down 83.2% YoY), while the FY2025 annual figure was $1.9 million, down 82.86% from the prior year.
• Tax Provisions was $985000.0 for Q1 2026 at Novavax, up from $376000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $7.4 million in Q4 2024 to a low of -$2.3 million in Q4 2022.
• Historically, Tax Provisions has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Tax Provisions sank 128.2% in 2023, then soared 1641.96% in 2024.
• A 5-year view of Tax Provisions shows it stood at -$2.3 million in 2022, then soared by 174.69% to $1.7 million in 2023, then surged by 341.29% to $7.4 million in 2024, then plunged by 94.95% to $376000.0 in 2025, then soared by 161.97% to $985000.0 in 2026.
• The last three Tax Provisions figures came in at $985000.0 (Q1 2026), $376000.0 (Q4 2025), and -$657000.0 (Q3 2025), per Business Quant data.